HOME >> BIOLOGY >> NEWS
Growth factor signals influence balance between normal growth and cancerous growth

For many biological processes, the Goldilocks Principle rules. You don't want too much, or too little, of something, you want it just right.

So it is with the body's delicate concentration of growth factors. Too much of a signaling protein called insulin-like growth factor-I (IGF-I) may fan the flames of cancer, while too little of the protein may cause short stature, dementia and osteoporosis, among other problems.

New research from The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine deepens the understanding of how the growth hormone/IGF system is affected by another important actor: p53, the tumor suppressor gene that puts the brakes on cancer. The interplay of the two signaling pathways reinforces questions about the long-term risks of prescribing growth hormone and IGF-I to patients, at the same time that it may suggest a future new avenue for cancer therapy.

The study, which used cell cultures and mice, was published in the October issue of Cancer Biology & Therapy.

"It was already known that the tumor suppressor protein p53, which causes a cell to stop growing or to self-destruct, also acts on genes in the growth hormone/IGF axis to turn down IGF signaling," said pediatric endocrinologist and lead author Adda Grimberg, M.D., of The Children's Hospital of Philadelphia. "In this paper we showed that p53 increases production of insulin-like growth factor binding protein-2, an interaction that was not previously known." That protein, abbreviated as IGFBP-2, binds to IGF-I, and thus makes the growth factor less available to act on the body's tissues.

When the authors used genes to halt IGFBP-2 production by prostate cancer cells in culture, they found that p53 lost its ability to block IGF-I from activating one of its major signaling targets in those cells.

IGF-I is important because, along with naturally produced human growth hormone, it is the major regulato
'"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
9-Nov-2006


Page: 1 2 3

Related biology news :

1. Growth factors and environment combine to increase brain maturation
2. Growth factor triggers growth of new blood vessels in the heart
3. Growth factor-promoting angiogenesis expressed in tumor cells and normal neurons
4. Growth hormone is made in the brain, report scientists
5. Growth hormone, obesity can trigger sleep apnea in some kids
6. Growth in biomass could put US on road to energy independence
7. Growth disorder gene plays a big role in normal size variation
8. Growth factor in baby formula could reduce NEC, most devastating GI disease in preemies
9. Growth in the sea comes down to a struggle for iron
10. Growth of common skin cancer blocked in gene-switch mice
11. Growth factors confer immortality to sperm-generating stem cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/19/2020)... ... 17, 2020 , ... Shoreline Biome , a microbiome ... level, recently unveiled a convenient new solution for the generation of 16S and ... capabilities as the Shoreline Complete kit. It is a convenient solution for microbiome ...
(Date:3/11/2020)... (PRWEB) , ... March 11, 2020 , ... ... and telemedicine company backed by Siemens Healthineers and several healthcare VC firms introduces ... over 100,000 people in over 100 countries and has caused over 4,000 fatalities ...
(Date:3/5/2020)... ... March 05, 2020 , ... ... Scientific Advisory Board (SAB) comprised of the industry’s key opinion leaders and ... centers, and private industry. Cytonus is a leading cell-based platform technology company ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... , ... February 18, 2020 , ... ... for characterizing microbiome populations down to the strain level, recently unveiled a novel ... designed for efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA ...
(Date:2/13/2020)... ... 2020 , ... Arriello , a provider of market ... Vault Safety™ as part of the company’s continued growth in pharmacovigilance operations. ... safety information such as SUSARs and ICSRS, aggregate report production, signal management, and ...
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced it is now registering ... Las Vegas. The course is hands on involving real patients and stem cell biologics, ... the Comprehensive Stem Cell Training Course has received rave reviews from attendees, who love ...
(Date:2/3/2020)... , ... February 03, 2020 , ... ... Financial Services Firm Travel, Law Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry ... listed quarterly. Each Index illustrates the following statistics:, ...
Breaking Biology Technology:
Cached News: